Generic lipitor if Ranbaxy were successful in its patent challenge, a generic Lipitor could be on the market as soon as 2006, he surmised. Generic lipitor to contact the reporter on this story: Susan Decker in Washington at (1) (202) 624-1941 or sdecker1bloomberg. The rankings report, based on NDC’s monthly pharmaceutical audit, noted that Lipitor’s total volume rose 6 percent last year to more than 69 million prescriptions. The company also faces patent expires on two other blockbusters within generic lipitor the next 18 months. ASTRAZENECA SAID new data showed its experimental drug Crestor was better at cutting cholesterol levels than Pfizer’s top-selling Lipitor. Each side said it would appeal the part of the judgment Generic lipitor it had lost. Additionally, Lipitor is not the only statin that raises HDL’s; both Zocor and Pravachol similarly raise HDL’s, by about 5% to 13%. NEW YORK — Pfizer Inc. New Analysis of the Treating to New Targets (TNT) Trial In a pre-specified analysis of more than 5,300 U. The ruling will have no effect on a pending challenge to the basic atorvastatin patent in Germany by the same two companies. Other clients made the transition generic lipitor more gradually, relying on market run-out, while some moved the Rx version of Claritin to a higher-tier copay. Some Generic lipitor critics claimed that it miserably failed dying patients. Crestor’s launch was set back by up to a year in July when the US Food and Drug Administration asked for additional safety data on the product. The Patent Office had conducted a re-examination of the ‘893 patent in response to a request by a law firm that represented the generic company Ranbaxy Laboratories Limited. Patients with stable coronary heart disease from the TNT trial: * Lipitor 80 mg provided significantly better clinical outcomes at almost no additional cost over five years compared with Lipitor 10 mg (the five-year cost of the 80 mg dose was $181 more). My envy was amplified when I read in the newspapers that he received at least $1 Generic lipitor 35 million to serve a two-year stint as Pfizer’s outdoorsy pitchman for Lipitor. Health plan formularies during 2Q 06. Michael Berelowitz, generic lipitor senior vice president of Pfizer’s global medical division. Patents on medicines that generate more than 40 percent of industry revenue will expire within five years, and the pace of new approvals by regulators is slowing, Moody’s said in a statement today.